OHR Pharmaceutical Inc.

About OHR

OHR Pharmaceutical Pipeline

OHR is focused on the development of novel therapeutics for the treatment of serious and unmet medical needs.

Learn More

Latest News

Ohr Pharmaceutical Announces Appointment of David Brown, MD as Chair of Phase 3 Clinical Program Steering Committee

Read More »

Ohr Pharmaceutical Announces Presentations at the 2016 Association for Research in Vision and Ophthalmology (ARVO) Conference in Seattle, WA

Read More »
View All News